Global Academy of Women's Cancer

Name: Global Academy of Women's Cancer
Address: Friedenstraße 58, Neuenhagen, 15366, DE
Telephone: +4933424268913

Startseite
Deutschland
Neuenhagen
Global Academy of Women's Cancer

Kontaktinformationen, Karte und Wegbeschreibungen, Kontaktformulare, Öffnungszeiten, Dienstleistungen, Bewertungen, Fotos, Videos und Ankündigungen von Global Academy of Women's Cancer, Friedenstraße 58, Neuenhagen.

The Global Academy of Women´s Cancer was initiated by Andreas du Bois, Jonathan Ledermann, Sherko Kümmel and Peter Schmid, to offer a unique global training concept, with key opinion leaders in the fields of gynaecological oncology and breast cancer.

10/09/2026

Are we moving toward more precise adjuvant treatment in HR-positive early breast cancer? These updates point toward a more tailored approach—helping define who may benefit from less treatment and who may benefit from more.

27/08/2026

Can we give bone therapy less often in metastatic breast cancer? 🦴

Data from the REDUSE study highlights a major practice-changing insight for bone-targeted therapy 👀 >>>

12/08/2026

When the tumour changes course mid-treatment: the ESR1 mutation, explained.

In HR-positive, HER2-negative metastatic breast cancer, the oestrogen receptor can change over time. When an ESR1 mutation appears, the tumour learns to grow even without oestrogen, and some hormone therapies start to lose their grip.

But this isn’t a dead end. It’s a signpost. 🔎

Highlights from the GAWC 2026 webinar:

▪️ ESR1 mutations can be picked up in the blood, often before the disease visibly progresses
▪️ An early switch to camizestrant + a CDK4/6 inhibitor can roughly double the time to progression (SERENA-6)
▪️ After further progression, elacestrant — an oral SERD in tablet form — is another option

The takeaway: ESR1 is not an endpoint. It points to new treatment options.

Swipe through to see how detecting the mutation early can reshape the treatment path ➡️

For educational purposes; not a substitute for individual medical advice.

20/07/2026

What does the SERENA-6 trial mean for everyday clinical practice? At the GAWC Webinar 2026, Prof. Dr. Nadia Harbeck discussed this pivotal study presented at ASCO, highlighting a crucial topic: the gap between a strong clinical trial signal and its broad implementation in routine patient care.

🧬 The SERENA-6 Strategy
The trial evaluated whether liquid biopsy can detect emergent ESR1 mutations during first-line AI + CDK4/6 inhibitor therapy before radiologic progression, allowing for an early switch to camizestrant.

📊 How the Audience Voted
We asked our international audience if they would screen all patients for molecular progression via liquid biopsy if routine care reimbursement were available. With nearly 300 participants voting, the responses were highly nuanced:

60% would use liquid biopsy only in selected patients.
25% would use it for all patients.
10% were not convinced by the current data.
5% wanted to reflect further after the webinar.

The results clearly underline how much discussion is still needed regarding clinical relevance versus real-world implementation.

💬 What is your approach?
Would you align with the selective majority, or do you favor universal screening once reimbursed? Share your perspective in the comments! 👇

08/07/2026

📊 GAWC Highlights: Insights from the Live Webinar
We are sharing an exclusive highlight from our recent webinar focused on Metastatic Breast Cancer! During the live broadcast, we asked our community of oncology specialists an important clinical question regarding optimal treatment intervals.

❓ The Question:
“For patients with stable bone metastases after approximately six months, I preferentially prescribe...”

📈 Live Poll Results:
The live audience poll during the GAWC 2026 webinar revealed a clear trend:
Most common response: Denosumab every 12 weeks

💬 What is your approach in clinical practice?
Medical guidelines evolve, and real-world clinical strategies vary. Would you make the same choice in your everyday practice?

Share your perspective and clinical experiences in the comments below! 👇

15/06/2026

‼️Reminder: the GAWC live webinar takes place tomorrow 👀

Join the Global Academy of Women’s Cancer on June 16 for a live webinar dedicated to current perspectives in breast cancer care.

The session will feature:

▫️Prof. Dr. Nadia Harbeck
Early Breast Cancer

▫️Prof. Dr. Peter Schmid
Advanced Breast Cancer

Moderation:
Prof. Dr. Sherko Kümmel (Sherko Kümmel)

📅 Tomorrow, June 16
🕡 18:30–20:30 Uhr
💻 Live Webinar

👉Last chance to register via link in bio.🔗

12/06/2026

International congress update 👀
From 17–19 June 2026, the ESMO Gynaecological Cancers Congress 2026 will take place in Copenhagen, Denmark, with online access also available.

For professionals in gynaecological oncology, this represents an important international appointment to follow scientific updates, expert discussions and current developments across gynaecological malignancies.

At GAWC, we believe that keeping the expert community informed is part of supporting continued scientific exchange in women’s cancer care.

12/05/2026

🌐 LIVE WEBINAR: Updates on Breast Cancer Treatment
Join the Global Academy of Women’s Cancer for an insightful live webinar featuring leading experts in the field of oncology.

We are diving deep into the latest developments in breast cancer care, from early-stage diagnosis to advanced treatment strategies.

🎙️ Meet Our Speakers:
• Prof. Dr. Nadia Harbeck: Discussing Frühes Mammakarzinom (Early Breast Cancer).
• Prof. Dr. Peter Schmid: Providing insights on Fortgeschrittenes Mammakarzinom (Advanced Breast Cancer).
• Prof. Dr. Sherko Kümmel: Leading the session as our Moderator.

📅 Save the Date:
• When: 16 June 2026
• Time: 18:30 – 20:30 UHR
• Where: Online via Live Webinar

Don’t miss this opportunity to learn from the best in the field and stay at the forefront of women’s cancer research and treatment.

🔗 How to Join:
Ready to secure your spot? Click the link in our bio to register now!

25/04/2026

Dr. Ayşe Özatılgan, Senior Medical Director for Medical Affairs at Menarini Stemline, sharing her key takeaways from the Global Academy of Women’s Cancer 2026 in Istanbul.

During this landmark two-day program—the first of its kind in Istanbul—over 80 HCPs gathered from across the globe, including Türkiye, Saudi Arabia, Qatar, Kuwait, Libya, UAE, France, and Germany. 🌍

💡 Focus on Metastatic Breast Cancer
Dr. Özatılgan discusses the cutting-edge data reviewed during the congress, focusing on:
• ER-positive/HER2-negative
• Triple Negative
• HER2-positive disease

We’re proud to lead these conversations and look forward to seeing you at the next GAWC event! 💖

Adresse

Friedenstraße 58
Neuenhagen
15366

Telefon

+4933424268913

Webseite

https://global-academy-of-womens-cancer.org/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Global Academy of Women's Cancer erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Service Kontaktieren

Nachricht an Global Academy of Women's Cancer senden:

Wollen Sie Ihr Service zum Top-Veranstaltung/Veranstaltungsort in Neuenhagen machen?